As of 2025-08-11, the Intrinsic Value of Terns Pharmaceuticals Inc (TERN) is -5.21 USD. This TERN valuation is based on the model Peter Lynch Fair Value. With the current market price of 6.08 USD, the upside of Terns Pharmaceuticals Inc is -185.68%.
Based on its market price of 6.08 USD and our intrinsic valuation, Terns Pharmaceuticals Inc (TERN) is overvalued by 185.68%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -5.21 - -5.21 | -5.21 | -185.68% |
| P/E | (19.63) - (19.94) | (20.16) | -431.6% |
| DDM - Stable | (12.12) - (45.15) | (28.64) | -571.0% |
| DDM - Multi | (11.30) - (32.62) | (16.77) | -375.8% |
| Market Cap (mil) | 531.03 |
| Beta | 2.05 |
| Outstanding shares (mil) | 87.34 |
| Enterprise Value (mil) | 531.03 |
| Market risk premium | 4.60% |
| Cost of Equity | 8.05% |
| Cost of Debt | 5.00% |
| WACC | 6.51% |